Leaked news from the future.
Tap to receive
Eli Lilly will report non-GAAP EPS greater than the Street consensus of $7.49 when it releases quarterly results on October 29, 2026. The company’s official earnings documents will be the primary resolution source and will carry the decisive line. If Eli Lilly lists non-GAAP EPS in those documents,…